1. A Combination of Flaxseed Oil and Astaxanthin Improves Hepatic Lipid Accumulation and Reduces Oxidative Stress in High Fat-Diet Fed Rats.
- Author
-
Xu J, Rong S, Gao H, Chen C, Yang W, Deng Q, Huang Q, Xiao L, and Huang F
- Subjects
- Acetyl-CoA Carboxylase genetics, Acetyl-CoA Carboxylase metabolism, Animals, Cholesterol metabolism, Diet, High-Fat, Dietary Fats, Fatty Acid Synthases genetics, Fatty Acid Synthases metabolism, Lipid Peroxidation drug effects, Liver metabolism, Male, Non-alcoholic Fatty Liver Disease physiopathology, Oxidoreductases genetics, Oxidoreductases metabolism, PPAR gamma genetics, PPAR gamma metabolism, Rats, Rats, Sprague-Dawley, Sterol Regulatory Element Binding Protein 1 genetics, Sterol Regulatory Element Binding Protein 1 metabolism, Triglycerides blood, Xanthophylls administration & dosage, Linseed Oil administration & dosage, Liver drug effects, Non-alcoholic Fatty Liver Disease diet therapy, Oxidative Stress drug effects
- Abstract
Hepatic lipid accumulation and oxidative stress are crucial pathophysiological mechanisms for non-alcoholic fatty liver disease (NAFLD). Thus, we examined the effect of a combination of flaxseed oil (FO) and astaxanthin (ASX) on hepatic lipid accumulation and oxidative stress in rats fed a high-fat diet. ASX was dissolved in flaxseed oil (1 g/kg; FO + ASX). Animals were fed diets containing 20% fat, where the source was lard, or 75% lard and 25% FO + ASX, or 50% lard and 50% FO + ASX, or FO + ASX, for 10 weeks. Substitution of lard with FO + ASX reduced steatosis and reduced hepatic triacylglycerol and cholesterol. The combination of FO and ASX significantly decreased hepatic sterol regulatory element-binding transcription factor 1 and 3-hydroxy-3-methylglutaryl-CoA reductase but increased peroxisome proliferator activated receptor expression. FO + ASX significantly suppressed fatty acid synthase and acetyl CoA carboxylase but induced carnitine palmitoyl transferase-1 and acyl CoA oxidase expression. FO + ASX also significantly elevated hepatic SOD, CAT and GPx activity and GSH, and markedly reduced hepatic lipid peroxidation. Thus, FO and ASX may reduce NAFLD by reversing hepatic steatosis and reducing lipid accumulation and oxidative stress.
- Published
- 2017
- Full Text
- View/download PDF